Insider holders · CIK 0001722964
Y-mAbs Therapeutics, Inc. · YMAB
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Biotech ApS WG10% Owner | 5,010,000 | — | 5,010,000 | Sep 20, 2018 · 6:04 pm EDT | Form 3 |
| Johan Wedell-WedellsborgDirector | — | 5,010,000 | 5,010,000 | Sep 20, 2018 · 6:03 pm EDT | Form 3 |
| James HealyDirector | — | 2,104,278 | 2,104,278 | Sep 25, 2018 · 8:41 pm EDT | Form 4 |
| Moller San Pedro Claus JuanChief Executive Officer | 872,928 | 872,928 | 1,745,856 | Sep 25, 2018 · 4:37 pm EDT | Form 4 |
| Ashu TyagiDirector | — | 1,392,740 | 1,392,740 | Sep 26, 2018 · 4:16 pm EDT | Form 4 |
| Thomas GadPresident and Chairman | — | 1,030,557 | 1,030,557 | Sep 20, 2018 · 6:03 pm EDT | Form 3 |
| Bo KruseEVP, CFO, Secy & Treas. | 300,000 | 57,077 | 357,077 | Sep 20, 2018 · 5:59 pm EDT | Form 3 |
| Torben Lund-HansenSr. VP and Head of Tech Op | — | 45,662 | 45,662 | Sep 20, 2018 · 6:01 pm EDT | Form 3 |
| Gregory S RaskinDirector | 5,882 | — | 5,882 | Sep 20, 2018 · 6:02 pm EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.